Johnson & Johnson
JNJNASDAQ·Health Care
Company Overview
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.
- Industry
- Pharmaceuticals
Financial Summary
- Revenue (TTM)
- $79.99B
- Net Income (TTM)
- $17.94B
- Total Assets
- $167.56B
- Total Debt
- $27.35B
- Total Equity
- $74.02B
- Market Cap
- -
Valuation Metrics
- P/E Ratio
- -
- P/B Ratio
- -
- Profit Margin
- 22.43%
- ROE
- 24.24%
- ROA
- 10.71%
- Dividend Yield
- -